Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Azacitidine in Previously Untreated Patients With TP53-Mutant Acute Myeloid Leukemia

Daver N., Vyas P., Chao MP., Xing G., Renard C., Ramsingh G., Sallman DA., Wei AH.

Type

Conference paper

Publication Date

2022-01-01T00:00:00+00:00

Volume

97

Pages

S5 - S6

Permalink Close